Delivery Order SPE2DB20D1100-SPE2DB25FE3Y7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Methylphenidate 10 mg/9-hour patches (30-count units) with a ceiling value of $9,352.51. This competitively awarded, firm fixed-price delivery order is not set aside for any specific business category and is scheduled for completion by August 12, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Methylphenidate transdermal patches. The award, valued at $1,283.20, is for a firm fixed-price contract with a completion date of November 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- The Defense Logistics Agency awarded a $1,209.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30 units of 10mg/9hr patch methylphenidate. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is to be completed between September 18-19, 2023. As the DLA is responsible for procuring pharmaceuticals and medical supplies for the Department of Defense, this order is likely to support treatment of attention deficit...
- The Defense Logistics Agency Troop Support Medical awarded a $1,495.26 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 mg/9 hour transdermal patches of methylphenidate hydrochloride. Place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The delivery order is for a single day's supply of the medication and is to be completed by August 29, 2023. As the Defense Logistics Agency manages the Department of Defense's medical logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Methylphenidate ER(LA) 20mg tablets (100-count units) under a firm fixed-price contract valued at $1,511.72. This is a non-set-aside competitive award with an ultimate completion date of July 29, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is the vendor's corporate office in...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,147.00 firm fixed-price contract is for the supply of Methylphenidate 20 mg/9hr patches, which are used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $1,147.00 and a completion date of September 26, 2024. This award is not a set-aside contract. AmerisourceBergen holds an Indefinite...
- The Defense Logistics Agency awarded a $4,495.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate ER 18 mg, with an ultimate completion date of August 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,565.88 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of 4,563,999,787 units of Methylphenidate Patch 30's 30MG, a pharmaceutical product. The contract has a ceiling value of $1,719.73 and a period of performance through March 18, 2024. The contract is a firm fixed price delivery order and does not have a set-aside designation. In...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,448.52 to supply Methylphenidate ER 36 mg tablets (100-count units) with an ultimate completion date of August 19, 2025. The contract is classified as a non-set-aside, competitively awarded delivery order with firm fixed pricing. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE3Y7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,052.12 to AmerisourceBergen Drug Corp for Methylphenidate 20 mg/9-hour patches (30 count) on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen Drug Corp's expansive pharmaceutical supply agreement with the Defense Logistics Agency, which includes a prime IDC valued at $999,999,999.00 and running through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies critical medications and medical commodities to military healthcare systems, the Defense Health Agency, and other government healthcare organizations. The methylphenidate order supports the military's ongoing medical supply requirements, with the medication used for attention deficit hyperactivity disorder treatment within federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/2/25 |